Philippe Kestemont

A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines

Benjamin Ascher, Benjamin Zakine, Philippe Kestemont et al. · Journal of the American Academy of Dermatology · 2004 · 182 citations

Microbial Toxin, Glabellar Lines, Botulinum Toxin A +3

Full-Face Rejuvenation Using a Range of Hyaluronic Acid Fillers: Efficacy, Safety, and Patient Satisfaction over 6 Months

Berthold Rzany, Hugues Cartier, Philippe Kestemont et al. · Dermatologic Surgery · 2012 · 81 citations

Efficacy and safety of a new hyaluronic acid dermal filler in the treatment of severe nasolabial lines - 6-month interim results of a randomized, evaluator-blinded, intra-individual comparison study

Benjamin Ascher, Christiane Bayerl, Patrick Brun et al. · Journal of Cosmetic Dermatology · 2011 · 55 citations

Botulinum toxin A in the treatment of glabellar lines: Scheduling the next injection

Benjamin Ascher, Benjamin Zakine, Philippe Kestemont et al. · Aesthetic Surgery Journal · 2005 · 55 citations · Full text

Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines

Benjamin Ascher, Berthold Rzany, Philippe Kestemont et al. · Aesthetic Surgery Journal · 2019 · 29 citations · Full text

Microbial Toxin, Toxinology, Medicine +9